XBIO
Xenetic Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.94M
P/E Ratio
—
EPS
$-1.58
Beta
2.21
52W High
$13.93
52W Low
$1.90
50-Day MA
$2.87
200-Day MA
$2.96
Dividend Yield
—
Profit Margin
-90.10%
Forward P/E
—
PEG Ratio
0.00
About Xenetic Biosciences Inc
Xenetic Biosciences, Inc., a biopharmaceutical company, is focused on advancing XCART, a customized chimeric antigen receptor T (CAR T) platform technology designed to target patient-specific tumor neoantigens. The company is headquartered in Framingham, Massachusetts.
Fundamentals
| Revenue (TTM) | $2.98M |
| Gross Profit (TTM) | $2.98M |
| EBITDA | $-5.75M |
| Operating Margin | -81.30% |
| Return on Equity | -40.00% |
| Return on Assets | -23.20% |
| Revenue/Share (TTM) | $1.75 |
| Book Value | $3.23 |
| Price-to-Book | 0.93 |
| Price-to-Sales (TTM) | 2.33 |
| EV/Revenue | 0.069 |
| EV/EBITDA | 1.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 18.10% |
| Shares Outstanding | $2.29M |
| Float | $1.78M |
| % Insiders | 10.24% |
| % Institutions | 10.28% |
Historical Volatility
HV 10-Day
51.34%
HV 20-Day
62.11%
HV 30-Day
64.16%
HV 60-Day
83.36%
HV Rank
—
Volatility is currently contracting
Data last updated: 5/1/2026